InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2023-04-19 00:00:00 ET · period of report 2023-04-17 · accession 0001415889-23-006694 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-04-19 2023-04-17 PTCT Boulding Mark Elliott EVP AND CLO M - OptEx $30.86 +61.9K 134.0K +86% +$1.91M
DM 2023-04-19 2023-04-17 PTCT Boulding Mark Elliott EVP AND CLO S - Sale+OE $51.42 -61.9K 75.4K -45% -$3.18M
DM 2023-04-19 2023-04-17 PTCT Boulding Mark Elliott EVP AND CLO M - OptEx $30.86 -61.9K 0 -100% -$1.91M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-04-17 M A 3,292 $30.86 78,670 D — —
2 Common Common Stock 2023-04-17 S D 3,292 $51.42 75,378 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.00 to $51.79 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2023-04-17 M A 58,631 $30.86 134,009 D — —
4 Common Common Stock 2023-04-17 S D 58,631 $51.42 75,378 D — — (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.00 to $51.825 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5 Derivative Stock Option (Right to Buy) 2023-04-17 M D 3,292 $30.86 58,631 D $30.86 · — to 2026-01-03 3,292 Common Stock (F4) Currently exercisable.
6 Derivative Stock Option (Right to Buy) 2023-04-17 M D 58,631 $30.86 0 D $30.86 · — to 2026-01-03 58,631 Common Stock (F4) Currently exercisable.